TCT test results are mainly divided into normal and abnormal. Abnormal results usually need to be combined with HPV tests, or further tests to confirm the diagnosis. TCT test results generally include the following: no intraepithelial lesions and malignant cells are seen, which is a normal result; benign reactive lesions including inflammation, epidermal cell atrophy, intrauterine contraceptive device reaction, radiation therapy reaction, etc., which basically also belong to the normal report card; trichomonas, mycobacterial and other infections, which can be generally targeted for treatment; atypical squamous cells, which include those that cannot be clearly meaningful or do not exclude highly lesions, which generally require colposcopy and multi-point biopsy of cervical tissue to confirm the diagnosis; low-grade squamous epithelial lesions generally refer to suspicious precancerous lesions, colposcopy and biopsy are recommended, with regular review; high squamous epithelial lesions, which generally require colposcopy and cervical biopsy and related treatment, because further development may be cervical cancer. In conclusion, cervical cancer screening, i.e. TCT and HPV, is recommended for all women over 30 years of age. If normal, regular screening can be done annually, and if abnormal, further colposcopy and biopsy are needed, and cervical conization or hysterectomy is done if necessary. Cervical vaccination is currently available for those who can afford it.